Sarah Boyd is an Infectious Disease physician affiliated with Saint Luke's Health System. OpenAlex indexes 19 publications with 337 citations (h-index 7); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5844 NW Barry Rd Ste 300
Kansas City, MO 641541483
Telephone
816-880-6238Registry record last updated 15 Nov 2017.
Clinical trials
- Catheter Management After Pelvic Reconstructive Surgery
Sponsor: Hartford Hospital
Overall officialCompletedNCT03071211
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- PFIZER INC.Program year20251 payment
- GlaxoSmithKline, LLC.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
96.3%Cephalosporin Antibacterial21.6%Ceftriaxone48%Cefepime Hcl32%Cefazolin Sodium20%Part D<11 patientsPenicillins with extended spectrum12.1%Amoxicillin62%Amoxicillin-Clavulanate Potass38%Part D<11 patients+ 13 more classes in this area
Nervous system
3.7%Gabapentinoids3.7%Gabapentin100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Pluard, MD
Saint Luke's Health System
Paul Chan, MD
Saint Luke's Health System
Bartosz Grobelny, MD
Saint Luke's Health System
Gurpreet Gandhoke, MD
Saint Luke's Health System
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
Derrick W. Crook
John Radcliffe Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”